Blood Pressure Monitors Market to Surge at 9.1%, Increasing Regulatory Approvals to Enable Growth and to Rise Impressively Incorporation of Digitalization to Provide Growth Impetus.
Pune, India -- (SBWIRE) -- 06/17/2019 -- The Global Blood Pressure Monitors Market is likely to grow exponentially driven by the increasing FDA approvals for newer devices. According to a report published by Fortune Business Insights, titled "Blood Pressure Monitors Market Size, Share and Global Trend by Product Type (Sphygmomanometers, Digital Blood Pressure Monitors, Ambulatory Blood Pressure Monitors & Hospitals), End User (Ambulatory Surgery Centers & Clinics, Home Healthcare & Others) and Geography Forecast till 2025," the market was valued at US$ 1,037.2 Mn in 2017. Fortune Business Insights states that the market is likely to expand at a CAGR of 9.1% in the forecast period and will be valued at around US$ 2,074.6 Mn by the end of 2026.
Sample PDF Brochure at https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/blood-pressure-monitors-market-100059
Some of the major companies that are present in the Global Blood Pressure Monitors Market are;
- American Diagnostic Corporation
- Welch Allyn
- Nihon Kohden Corporation
- GE Healthcare
- Smith's Group
- Masimo Corporation
- Omron Healthcare
- Other players
Omron Introduces Blood Pressure Monitors with EKG Capability
In May 2019, Omron introduced a new blood pressure monitoring device with the ability to read electrocardiogram pulses. The device had earlier received clearance from the Food and Drug Administration (FDA) for clinical use. The company made these products available for commercialization in May 2019, after a series of successful clinical trials. Omron's blood pressure monitors are quickly adopted by many healthcare professionals due to their efficiency and EKG capability. Omron's innovative blood pressure devices have encouraged its competitors, as a result of which many healthcare companies are acting swiftly to introduce their own products. Many renowned companies are now focusing on investing more in the research and development of new blood pressure monitors and introducing newer concepts as well as additional features within the devices. The success of Orman's product had a massive impact on the global market and is likely to favor the growth of the global blood pressure monitoring market in the forecast period.
Major Table of Content Blood Pressure Monitors Market are;
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
CardieX (CDX) receives China FDA Approval for SphygmoCor Inside
In April 2019, CardieX announced that it has received approval from the Chinese Food and Drug Administration for clinical usage and commercialization of its latest blood pressure monitoring product. cardiac announced Oscar 2 ambulatory blood pressure monitor (ABPM), a device launched in collaboration with SunTech Medical Inc. The device received worldwide allocates from renowned healthcare critics and regulatory authorities due to its exceptional capabilities.
The high prevalence of disorders such as hypertension and others leading to diabetes and heart disease has led to increased adoption of Oscar 2 in this particular region Hypertension affects over half of the total adult population in China and is a major cause of heart failures and other heart-related disorders. Therefore, the increasing adoption of Oscar 2 has affected the global blood pressure monitors market in a positive way and is likely to influence the market in the forthcoming years.
Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/blood-pressure-monitors-market-100059
Digital Blood Pressures are by far, the Most Used Product Type
Digital blood pressure monitors are a growing favorite among healthcare professionals. The high caliber functional ability and precise readings due to digital devices have led to increasing use among end users, globally. Single-handedly, the digital blood pressure monitor devices have accounted for around 64% of the total market share. Product benefits such as low cost and lesser time for diagnosis are likely to favor the digital blood pressure devices and they will continue to dominate the global market in the forecast period.
Some of the leading companies that are operating in the global digital blood pressure monitors market are American Diagnostic Corporation, Welch Allyn, Philips, Nihon Kohden Corporation, GE Healthcare, Smiths Group, Masimo Corporation, and Omron Healthcare.